News

Latest News News

Autologous Bone Marrow Cell Therapy Failed to Meet Primary Endpoint in Ischemic Heart Failure: CardiAMP-HF

Key Takeaways: Intramyocardial autologous bone marrow cell therapy was safe in patients…

Leah Kosyakovsky

SHR-1918 Safe, Significantly Lowered LDL-C and Triglycerides in Poorly Controlled Hyperlipidemia

Key Takeaways: SHR-1918, an ANGPTL3 inhibitor, significantly reduced LDL cholesterol by approximately…

Leah Kosyakovsky

AI-Based ECG Model Enhances Detection of Heart Attack and Need for Coronary Revascularization

Key Takeaways: A deep learning ECG model significantly outperforms clinician interpretation in…

Leah Kosyakovsky

AI Accurately Detected Severe AS on TTE but Uptake Low Amongst Clinicians: Insights from a Randomized Crossover Study

Key Points: In a randomized crossover study, authors assessed whether artificial intelligence…

Leah Kosyakovsky

PRAGUE-25: Lifestyle Modification Plus Antiarrhythmic Drugs Inferior to Catheter Ablation In Obese Patients

Key Points: Obesity increases the risk of atrial fibrillation (AF) by 19–29%…

Leah Kosyakovsky

ZENITH Trial: Sotatercept Significantly Reduces Major Morbidity and Mortality Events in High-Risk PAH Patients

Key Points: Pulmonary arterial hypertension (PAH) is a progressive disease with poor…

Leah Kosyakovsky

SUMMIT: Tirzepatide Improved Renal Function in Patients with HFpEF, Obesity, and CKD

Key Points The SUMMIT randomized control trial demonstrated that tirzepatide significantly reduced…

Leah Kosyakovsky

EKSTROM Trial: Low-dose Colchicine Reduced Total Plaque Volume on CCTA, but Not Low Attenuation Plaque

Key Points The COLCOT trial demonstrated colchicine improved coronary plaque characteristics in…

Leah Kosyakovsky

Dapagliflozin Reduced LVMI in Patients with CKD : DECODE-CKD

Key Points The DECODE-CKD trial investigated the effects of SGLT-2 inhibitor Dapagliflozin…

Leah Kosyakovsky

Benefit from Intensive BP Control Across Frailty Statuses – A Post-Hoc Analysis of ESPRIT trial

Key Points The ESPRIT trial assessed whether the efficacy and safety of…

Leah Kosyakovsky

EARLY TAVR: Delayed TAVR Linked with Increased Risk of Death, Stroke, HF, or HFH Within 2 Years

Key Points:  In this sub analysis of the EARLY TAVR trial, the…

Leah Kosyakovsky

Early, Short-Term Use of Rivaroxaban Plus DAPT Significantly Reduces Intracoronary Thrombus

Key Points:  In the ARISE-ARMYDA 7 trial, 40 patients who presented with…

Leah Kosyakovsky

Health360x.ai Successfully Implemented Decentralized Clinical Trials in Underserved Populations

Key Points: Health360x.ai is an AI-powered digital health platform designed to scale…

Leah Kosyakovsky

Coaching Intervention Did Not Increase Physical Function or Cardiac Rehabilitation Participation: MACRO

Key Points: Older adults have higher cardiovascular risk in conjunction with other…

Leah Kosyakovsky

0/1-Hour Algorithm Safe and Effective for Rapid Chest Pain Assessment in the ED: DROP-Asian ACS Trial

Key Takeaways: The 0/1-hour hs-cTn algorithm is safe, non-inferior to usual care,…

Leah Kosyakovsky

Routine Orbital Atherectomy Does Not Improve Outcomes vs Balloon Angioplasty for Severely Calcified Coronary Lesions: ECLIPSE Trial

Key Takeaways: Orbital atherectomy as a routine lesion preparation strategy prior to…

Leah Kosyakovsky

AI QCT Coronary Plaque Features More Predictive in Women: CONFIRM2 Registry

Key Points: Women are underdiagnosed and undertreated for CAD, despite higher prevalence…

Leah Kosyakovsky

AI-Quantitative CT Coronary Plaque Features Indicate Higher Relative CV Risk in Women: CONFIRM2 Registry

Key Takeaways: AI-based quantitative coronary plaque assessments significantly improve risk prediction for…

Leah Kosyakovsky